Medicare Enrolled
Dr. Ibrahim Hanna, M.D.
Internal Medicine · Glendora, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hanna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hanna
Dr. Ibrahim Hanna is an internal medicine specialist in Glendora, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hanna performed 1,778 Medicare services across 1,343 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hanna received a total of $10,691 from 50 pharmaceutical and/or device companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in CA
$10,691 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,778
Medicare services
Top 18% in CA for internal medicine
1,343
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
546 | $98 | $160 |
| Annual depression screening | 170 | $21 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
164 | $143 | $300 |
| Annual alcohol misuse screening, 5 to 15 minutes | 136 | $21 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
133 | $67 | $120 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
110 | $34 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $12 | $35 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
57 | $33 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
53 | $72 | $85 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
48 | $1 | $15 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
47 | $3 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $105 | $240 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
38 | $11 | $75 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
28 | $38 | $85 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
25 | $182 | $300 |
| Hemoglobin a1c level, by device for home use | 18 | $10 | $52 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $35 | $80 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
15 | $33 | $38 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
12 | $282 | $320 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $182 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,691
Total received (2018-2024)
Avg $1,527/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
567
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,440 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$251 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,392
2023
$1,581
2022
$1,007
2021
$1,628
2020
$1,689
2019
$1,918
2018
$1,475
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$226
AstraZeneca Pharmaceuticals LP
$219
Lilly USA, LLC
$189
Novo Nordisk Inc
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$147
PFIZER INC.
$75
Amgen Inc.
$74
Xeris Pharmaceuticals, Inc.
$45
GlaxoSmithKline, LLC.
$44
Kowa Pharmaceuticals America, Inc.
$39
Almatica Pharma LLC
$25
SANOFI-AVENTIS U.S. LLC
$22
Lundbeck LLC
$21
Dexcom, Inc.
$21
Antares Pharma, Inc.
$20
IBSA Pharma Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$19
Otsuka America Pharmaceutical, Inc.
$16
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 45.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,102
AstraZeneca Pharmaceuticals LP
$1,033
PFIZER INC.
$1,007
Lilly USA, LLC
$894
Novo Nordisk Inc
$709
GlaxoSmithKline, LLC.
$602
ABBVIE INC.
$592
Takeda Pharmaceuticals U.S.A., Inc.
$570
Boehringer Ingelheim Pharmaceuticals, Inc.
$444
Astellas Pharma US Inc
$313
Alexion Pharmaceuticals, Inc.
$275
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$255
Janssen Pharmaceuticals, Inc
$243
Allergan Inc.
$241
Allergan, Inc.
$214
AbbVie Inc.
$166
Stryker Corporation
$161
Horizon Therapeutics plc
$161
Merck Sharp & Dohme Corporation
$152
Amarin Pharma Inc.
$148
Kowa Pharmaceuticals America, Inc.
$121
Abbott Laboratories
$105
AbbVie, Inc.
$102
SANOFI PASTEUR INC.
$101
Antares Pharma, Inc.
$89
Bayer HealthCare Pharmaceuticals Inc.
$85
Novartis Pharmaceuticals Corporation
$65
Eisai Inc.
$64
Sunovion Pharmaceuticals Inc.
$59
Teva Pharmaceuticals USA, Inc.
$58
Exact Sciences Corporation
$53
IBSA Pharma Inc.
$53
Lundbeck LLC
$47
Almatica Pharma LLC
$47
Xeris Pharmaceuticals, Inc.
$45
Phadia US Inc.
$40
Otsuka America Pharmaceutical, Inc.
$36
Vanda Pharmaceuticals Inc.
$28
Regeneron Healthcare Solutions, Inc.
$25
Biohaven Pharmaceuticals, Inc.
$23
ARBOR PHARMACEUTICALS, INC.
$22
SANOFI-AVENTIS U.S. LLC
$22
Dexcom, Inc.
$21
Orexigen Therapeutics, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Currax Pharmaceuticals LLC
$14
Arbor Pharmaceuticals, Inc.
$13
Sanofi Pasteur Inc.
$13
Vertiflex, Inc.
$12
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · ANORO · AUSTEDO · Accent Pacemaker · Aimovig · Amitiza · Andexxa · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · Belviq · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVKEEZA · Edarbi · Enbrel · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GRALISE · HETLIOZ · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KEVEYIS · KRYSTEXXA · Kerendia · LATUDA · LEQVIO · LICART · LINZESS · LOREEV XR · LYRICA · Livalo · MAKO · MOUNJARO · MYRBETRIQ · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RAYOS · REXULTI · REYVOW · RINVOQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SYMBICORT · SYNTHROID · Saxenda · Superion ISS · Synthroid · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tirosint · Trintellix · UBRELVY · Ultomiris · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZENPEP · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
1,999
Per 100K population
20.3
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hanna is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hanna experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hanna performed 546 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hanna receive payments from pharmaceutical companies?
Yes. Dr. Hanna received a total of $10,691 from 50 companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanna's costs compare to other internal medicine physicians in Glendora?
Dr. Hanna's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Glendora
Browse internal medicine physicians in Glendora ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology